Purchase Order 75N92E20P00208

Georgetown University has been awarded a $14,910 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to generate EBV cell lines from July 17, 2023 through July 16, 2024. The prime contractor, Georgetown University, will deliver this cell line generation service for the Department of Health and Human Services in Washington, D.C. No subcontractors or set aside designations were indicated. This contract supports the NIH's mission to...

<p>The National Human Genome Research Institute awarded a purchase order to Georgetown University for $19,999.00 on December 18, 2019, for generic testing. Performance takes place in Bethesda, Maryland. The firm fixed-price order was completed on the award date. No small business set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Reprocell U.s.a., Inc. for $18,398.20 on January 30, 2020, for DNA extractions. Work is performed at Calverton, Maryland. The order is firm fixed price with an ultimate completion date of February 29, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Qiagen, LLC for $10,456.60 on August 16, 2016, with firm fixed price, no set-aside. Place of performance is Bethesda, Maryland. The order calls for molecular diagnostics consumables and reagents, including DNA/RNA extraction kits and related laboratory supplies. Ultimate completion date is December 22, 2020.</p>

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $23,856 firm fixed price purchase order contract to Georgetown University, a private non-profit university, for EBV transformation services from July 17, 2023 to July 16, 2024, with a completion date of January 31, 2025. This contract is not set aside for any preferred business type. Georgetown University is a long-standing federal contractor that provides a range of...

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $5,450.23 delivery order to Illumina, Inc. on August 15, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order carries a firm fixed-price structure and an ultimate completion date of September 14, 2018.</p>

<p>The National Human Genome Research Institute issued a $98,905.32 delivery order to Illumina, Inc. on August 22, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed-price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 30, 2017, with a ceiling value of $7,216.30 for genomic analysis equipment and services.</p> <p>Place of performance is North Bethesda, MD. The order is priced on a firm fixed-price basis and has an ultimate completion date of September 30, 2017.</p>